1. Whyte M.P. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016; 12(4): 233 - 246. doi: 10.1038/nrendo.2016.14.
2.
J.L., Whyte M.P. Alkaline phosphatase and hypophosphatasia. Calcif Tissue Int. 2016; 98(4): 398 - 416. doi: 10.1007/s00223-015-0079-1.
3. Алексеева И.А., Кисельникова Л.П., Петровская В.В., Лежнев Д.А., Дробышев А.Ю., Редько Н.А., Кунижев К.А. Оценка состояния тканей временных зубов детей с гипофосфатазией с помощью компьютерной микротомографии. Стоматология для всех. 2025; N 4 (113): 70 - 76. doi: 10.35556/idr-2025-4(113) 70 - 76.
4. Mornet E., Yvard A., Taillandier A., et al. A molecular-based estimation of the prevalence of hypophosphatasia in the European population. Ann Hum Genet. 2011; 75(3): 439 - 445. doi: 10.1111/j.1469-1809.2011.00642.x.
5. Гуркина Е.Ю., Воинова В.Ю., Кузенкова Л.М. и др. Гипофосфатазия. Обзор клинических случаев, опубликованных в РФ. РМЖ. 2021; 2: 42 - 48.
6. Rockman-Greenberg C. Hypophosphatasia. Pediatr Endocrinol Rev. 2013 Jun; 10 Suppl 2: 380-8. PMID: 23858621.
7. Whyte M.P. Hypophosphatasia. In: Thakker RV et al. eds. Genetics of Bone Biology and Skeletal Disease 2013. 1st ed. London, UK: Academic Press; 2013: 337-60.
8. Salles J.P. Hypophosphatasia: Biological and Clinical Aspects, Avenues for Therapy. Clin Biochem Rev. 2020 Feb; 41(1): 13 - 27. doi: 10.33176/AACB-19-00031. PMID: 32158059; PMCID: PMC7043401.
9. Conti F., Ciullini L., Pugliese G. Hypophosphatasia: clinical manifestation and burden of disease in adult patients. Clin Cases Miner Bone Metab. 2017 May-Aug; 14(2): 230 - 234. doi: 10.11138/ccmbm/2017.14.1.230. Epub 2017 Oct 25. PMID: 29263739; PMCID: PMC5726215.
10. Weber T.J., Sawyer E.K., Moseley S., Odrljin T., Kishnani P.S. Burden of disease in adult patients with hypophosphatasia: Results from two patient-reported surveys. Metabolism. 2016 Oct; 65(10): 1522-30. doi: 10.1016/j.metabol.2016.07.006. Epub 2016 Jul 19. PMID: 27621187.
11. Магеррамова С.Т., Тютюгина Ю.В., Белая Ж.Е. Диагностика гипофосфатазии во взрослом возрасте: клинические случаи и обзор литературы. Остеопороз и остеопатии. 2024; 27(4): 11 - 16.
12. Khan A.A., Brandi M.L., Rush E.T., Ali D.S., Al-Alwani H., Almonaei K., Alsarraf F., Bacrot S., Dahir K.M., Dandurand K., Deal C., Ferrari S.L., Giusti F., Guyatt G., Hatcher E., Ing S.W., Javaid M.K., Khan S., Kocijan R., Linglart A., M'Hiri I., Marini F., Nunes M.E., Rockman-Greenberg C., Roux C., Seefried L., Simmons J.H., Starling S.R., Ward L.M., Yao L., Brignardello-Petersen R., Lewiecki E.M. Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults. Osteoporos Int. 2024 Mar; 35(3): 431 - 438. doi: 10.1007/s00198-023-06844-1 Epub 2023 Nov 20. Erratum in: Osteoporos Int. 2024 May; 35(5): 933 - 934. doi: 10.1007/s00198-024-07048-x. PMID: 37982857; PMCID: PMC10866785.
13. Rush E., Brandi M.L., Khan A., Ali D.S., Al-Alwani H., Almonaei K., Alsarraf F., Bacrot S., Dahir K.M., Dandurand K., Deal C., Ferrari S.L., Giusti F., Guyatt G., Hatcher E., Ing S.W., Javaid M.K., Khan S., Kocijan R., Lewiecki E.M., Linglart A., M'Hiri I., Marini F., Nunes M.E., Rockman-Greenberg C., Roux C., Seefried L., Starling S.R., Ward L., Yao L., Brignardello-Petersen R., Simmons J.H. Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group. Osteoporos Int. 2024 Jan; 35(1): 1 - 10. doi: 10.1007/s00198-023-06843-2. Epub 2023 Nov 20. PMID: 37982855; PMCID: PMC10786745.
14. McKiernan F.E., Berg R.L., Fuehrer J. Clinical and radiographic findings in adults with persistent hypophosphatasemia. J Bone Miner Res. 2014; 29(7): 1651 - 1660.
15. Vieira L.H.R., Peixoto K.C.,
C.L., de Farias M.L.F., Madeira M. Active search of adult patients with persistently low serum alkaline phosphatase levels for the diagnosis of hypophosphatasia. Arch Endocrinol Metab. 2021 Nov 3; 65(3): 289 - 294. doi: 10.20945/2359-3997000000347. Epub 2021 Apr 12. PMID: 33844893; PMCID: PMC10065342.
16. Szabo S.M., Tomazos I.C., Petryk A., Powell L.C., Donato B.M.K., Zarate Y.A., Tiulpakov A., Martos-Moreno
Frequency and age at occurrence of clinical manifestations of disease in patients with hypophosphatasia: a systematic literature review. Orphanet J Rare Dis. 2019 Apr 25; 14(1): 85. doi: 10.1186/s13023-019-1062-0. PMID: 31023354; PMCID: PMC6485115.
17.
., Gawlik A.,
.,
. The Clinical Picture of Patients Suffering from Hypophosphatasia-A Rare Metabolic Disease of Many Faces. Diagnostics (Basel). 2022 Mar 30; 12(4): 865. doi: 10.3390/diagnostics12040865. PMID: 35453912; PMCID: PMC9031194.
18. Sugiyama Y., Watanabe T., Tajika M., Matsuhashi T., Shimura M., Fushimi T., Ichimoto K., Matsunaga A., Ebihara T., Tsuruoka T., Akiyama T., Murayama K.A. Japanese single-center experience of the efficacy and safety of asfotase alfa in pediatric-onset hypophosphatasia. Orphanet J Rare Dis. 2022 Feb 23; 17(1): 78. doi: 10.1186/s13023-022-02230-y. PMID: 35197081; PMCID: PMC8867653.
19. Dahir K.M., Dunbar N.S. Medical Management of Hypophosphatasia: Review of Data on Asfotase Alfa. Curr Osteoporos Rep. 2025 Mar 18; 23(1): 14. doi: 10.1007/s11914-025-00906-5. PMID: 40100438; PMCID: PMC11920343.
20. Mannes I., Rothenbuhler A., Merzoug V., Di Rocco F., Linglart A., Adamsbaum C. Imaging patterns in pediatric hypophosphatasia. Pediatr Radiol. 2022 May; 52(5): 998 - 1006. doi: 10.1007/s00247-021-05232-3. Epub 2021 Dec 2. PMID: 34854966.
21.
,
.,
, Prieto-Rivera J.C.,
.,
,
, Serrano-Gayubo A.K., Medina-Orjuela A.,
, Guerrero-Tinoco G.A.,
, Guarnizo-Zuccardi P., Herrera-Ortiz G., Rojas-Barrera C.,
,
, Arguinzoniz-Valenzuela S.L.,
., Del-Pino M., Viterbo GL, Seijo M.,
.,
, Brunetto O.H. Diagnosis, treatment, and follow-up of patients with hypophosphatasia. Endocrine. 2025 Feb; 87(2): 400 - 419. doi: 10.1007/s12020-024-04054-1.
22. Голоунина О.О., Рунова Г.Е., Фадеев В.В. Остеомаляция в практике эндокринолога: этиология, патогенез, дифференциальная диагностика с остеопорозом. Остеопороз и остеопатии. 2019; 22(2): 23 - 31.
23. Нароган Марина Викторовна, Рюмина Ирина Ивановна, Степанов А.В. Остеопения (метаболическая болезнь костей) у недоношенных: возможности диагностики, лечения и профилактики//Неонатология: Новости. Мнения. Обучение. 2014. N 3 (5).
24. Gifre L., Peris P., Monegal A., Martinez de Osaba M.J., Alvarez L.,
N. Osteomalacia revisited: a report on 28 cases. Clin Rheumatol. 2011 May; 30(5): 639-45. doi: 10.1007/s10067-010-1587-z. Epub 2010 Oct 15. PMID: 20949298.
25. Hypophosphatasia: Management AUTHOR: J Carl Pallais, MD, MPH, SECTION EDITOR Deborah E Sellmeyer, MD, DEPUTY EDITOR: Katya Rubinow, MD Literature review current through: literature-review-date This topic last updated: Mar 24, 2025. Uptodate.com
26. Tornero C., de Miguel E.,
., Balsa A., Aguado P. Prevalence of chondrocalcinosis and calcium pyrophosphate deposition disease in a cohort of adult patients with low alkaline phosphatase levels and a positive versus negative genetic ALPL study. JBMR Plus. 2024 Sep 26; 8(11): ziae124. doi: 10.1093/jbmrpl/ziae124. PMID: 39450343; PMCID: PMC11499678.
27.
., Mumm S.,
.,
., Peris P., Demertzis J.L., Whyte M.P. Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-aged sisters. J Bone Miner Res. 2014 Apr; 29(4): 929-34. doi: 10.1002/jbmr.2110. PMID: 24123110.
28. Lehane F., Malaise O., Von Frenckell C., Otto B., Docampo E, Ribbens C. Hypophosphatasia Presenting as a Chronic Diffuse Pain Syndrome with Extra-Articular Calcifications. J Clin Med. 2024 Apr 13; 13(8): 2263. doi: 10.3390/jcm13082263. PMID: 38673536; PMCID: PMC11051522.
29. Chew L.C., Tong C., Bryant C., Joshua F. Recognizing the clinical triad and dural calcification in adult hypophosphatasia. Rheumatology (Oxford). 2017 Jun; 56(6): 868. doi: 10.1093/rheumatology/kew424. Epub 2016 Dec 19. PMID: 27994097.
30. Yoshida H., Murakami T., Ogawa A., Sunouchi T., Hidaka N., Ito N., Murakami H., Kawasaki H., Akiyama T., Nakajima K., Yabe D., Yamamoto T. Adult hypophosphatasia presenting with recurrent acute joint pain. Endocrinol Diabetes Metab Case Rep. 2025 Jan 27; 2025(1): e240121. doi: 10.1530/EDM-24-0121. PMID: 39868560; PMCID: PMC11811822.
31.
, Ayuso Benavent C., Simoni P., Musa Aguiar P., Bazzocchi A., Aparisi F. Imaging of Bone Marrow: From Science to Practice. Semin Musculoskelet Radiol. 2022 Aug; 26(4): 396 - 411. doi: 10.1055/s-0042-1745803. Epub 2022 Sep 14. PMID: 36103883.
32. Jill H. Simmons, Eric T. Rush, Anna Petryk, Shanggen Zhou,
, Dual X-ray absorptiometry has limited utility in detecting bone pathology in children with hypophosphatasia: A pooled post hoc analysis of asfotase alfa clinical trial data, Bone, Volume 137, 2020, 115413, ISSN 8756 - 3282.
33. Kishnani P.S., Rockman-Greenberg C., Rauch F., Bhatti M.T., Moseley S., Denker A.E., Watsky E., Whyte M.P. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia. Bone. 2019 Apr; 121: 149 - 162. doi: 10.1016/j.bone.2018.12.011. Epub 2018 Dec 18. PMID: 30576866.
34. Whyte M.P., Leung E., Wilcox W., et al. Hypophosphatasia: a retrospective natural history study of the severe perinatal and infantile forms. Poster presented at the 2014 Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting. Vancouver, B.C., Canada, May 5, 2014. Abstract 752416.
35. Whyte M.P., Zhang F., Wenkert D., et al. Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. Bone. 2015; 75: 229 - 239. doi: 10.1016/j.bone.2015.02.022.
36. Bishop N., Munns C.F., Ozono K. Transformative therapy in hypophosphatasia. Arch Dis Child. 2016; 101(6): 514 - 515. doi: 10.1136/archdischild-2015-309579.
37. Anderson H.C., Harmey D., Camacho N.P., et al. Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice. Am J Pathol. 2005; 166(6): 1711 - 1720. doi: 10.1016/S0002-9440(10) 62481-9.
38. Braunstein N.А. Multiple fractures, pain, and severe disability in a patient with adult-onset hypophosphatasia. Bone Rep. 2016; 4: 1 - 4. doi: 10.1016/j.bonr.2015.10.005.
39. Whyte M. Hypophosphatasia. In: Thakker R.V., Whyte M.P., Eisman J., Igarashi T., editors. Genetics of bone biology and skeletal disease. London: Academic Press; 2013. p. 337 - 360.
40. Whyte M.P., Greenberg C.R., Salman N.J., et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med. 2012; 366(10): 904 - 913. doi: 10.1056/NEJMoa1106173. Fukazawa M., Tezuka J., Sasazuki M., Masumoto N., Baba H., Doi T., Tsutsumi Y., Mizuno Y., Mihara F., Nakayama H. Infantile hypophosphatasia combined with vitamin B6-responsive seizures and reticular formation lesions on magnetic resonance imaging: A case report. Brain Dev. 2018 Feb; 40(2): 140 - 144. doi: 10.1016/j.braindev.2017.07.015.
41. Whyte M.P., Coburn S.P., Ryan L.M., Ericson K.L., Zhang F. Hypophosphatasia: Biochemical hallmarks validate the expanded pediatric clinical nosology. Bone. 2018 May 1; 110: 96 - 106.
42. Rush E.T. Childhood hypophosphatasia: to treat or not to treat. Orphanet J Rare Dis. 2018 Jul 16; 13(1): 116.
43. Simon S., Resch H., Klaushofer K., Roschger P., Zwerina J., Kocijan R. Hypophosphatasia: From Diagnosis to Treatment. Curr Rheumatol Rep. 2018 Sep 10; 20(11): 69.
44. Khan A.A., Josse R., Kannu P., Villeneuve J., Paul T., Van Uum S., Greenberg C.R. Hypophosphatasia: Canadian update on diagnosis and management. Osteoporos Int. 2019 Sep; 30(9): 1713 - 1722.
45. Mornet E. Hypophosphatasia. Metabolism. 2018 May; 82: 142 - 155.
46. Briot K., Roux C. Adult hypophosphatasia. Arch Pediatr. 2017 May; 24(5S2): 5S71 - 5S73.
47. Kishnani P.S., Rush E.T., Arundel P., Bishop N., Dahir K., Fraser W., Harmatz P., Linglart A., Munns C.F., Nunes M.E., Saal H.M., Seefried L., Ozono K. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017 Sep; 122(1-2): 4 - 17. doi: 10.1016/j.ymgme.2017.07.010.
48. Michigami T., Ohata Y., Fujiwara M., Mochizuki H., Adachi M., Kitaoka T., Kubota T., Sawai H., Namba N., Hasegawa K., Fujiwara I., Ozono K. Clinical Practice Guidelines for Hypophosphatasia. Clin Pediatr Endocrinol. 2020; 29(1): 9 - 24.
49. Estey M.P., Cohen A.H., Colantonio D.A., Chan M.K., Marvasti T.B., Randell E., et al. CLSI-based transference of the CALIPER database of pediatric reference intervals from Abbott to Beckman, Ortho, Roche and Siemens Clinical Chemistry Assays: direct validation using reference samples from the CALIPER cohort. Clin Biochem. 2013; 46: 1197 - 219.
50. Ройтман А.П., Мамедов И.С., Сухоруков В.С. Референтные интервалы активности щелочной фосфатазы у детей в сыворотке крови. Лабораторная диагностика гипофосфатазии. Лабораторная служба. 2015; 4(1): 35 - 41. https://doi.org/10.17116/labs20154135-41.
51. Mornet E. Hypophosphatasia. Metabolism. 2018 May; 82: 142 - 155. doi: 10.1016/j.metabol.2017.08.013.
52.
,
C.,
F.,
S.,
T.,
V.,
B.,
M. Hypophosphatasia: A Unique Disorder of Bone Mineralization. Int. J. Mol. Sci. 2021, 22, 4303. https://doi.org/10.3390/ijms22094303.
53. Christine Hofmann C., Girschick H., Mornet E., Schneider D., Jakob F., Mentrup B. Unexpected high intrafamilial phenotypic variability observed in hypophosphatasia, European Journal of Human Genetics volume 22, pages1160 - 1164 (2014).
54. Mornet E. Molecular Genetics of Hypophosphatasia and Phenotype-Genotype Correlations. Subcell Biochem. 2015; 76: 25 - 43. doi: 10.1007/978-94-017-7197-9_2.
55. Ishiguro T. et al. Findings of amplitude-integrated electroencephalogram recordings and serum vitamin B6 metabolites in perinatal lethal hypophosphatasia during enzyme replacement therapy//Brain and Development. - 2019. - Т. 41. - N. 8. - С. 721 - 725.
56. Martos-Moreno G.A., Calzada J., Couce M.L., Argente J. Hipofosfatasia: manifestaciones
, recomendaciones
y opciones
[Hypophosphatasia: Clinical manifestations, diagnostic recommendations and therapeutic options]. An Pediatr (Engl Ed). 2018 Jun; 88(6): 356.e1 - 356.e11. Spanish. doi: 10.1016/j.anpedi.2017.06.004.
57. Girschick H.J., Schneider P., Haubitz I., et al. Effective NSAID treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasia. Orphanet J Rare Dis. 2006 Jun 28; 1: 24. doi: 10.1186/1750-1172-1-24.
58. Di Rocco F., Baujat G., Cormier-Daire V., Rothenbuhler A., Linglart A. Craniosynostosis and hypophosphatasia. Arch Pediatr. 2017 May; 24(5S2): 5S89 - 5S92. doi: 10.1016/S0929-693X(18) 30022-8.
59. Vogt M., Girschick H., Schweitzer T., Benoit C., Holl-Wieden A., Seefried L., Jakob F., Hofmann C. Pediatric hypophosphatasia: lessons learned from a retrospective single-center chart review of 50 children. Orphanet J Rare Dis. 2020 Aug 18; 15(1): 212. doi: 10.1186/s13023-020-01500-x.
60. Collmann H., Mornet E.,
., Beck C., Girschick H. Neurosurgical aspects of childhood hypophosphatasia. Childs Nerv Syst. 2009 Feb; 25(2): 217-23.
61. Graham B.L., Steenbruggen I., Miller M.R., Barjaktarevic I.Z., Cooper B..G, Hall G.L., Hallstrand T.S., Kaminsky D.A., McCarthy K., McCormack M.C., Oropez CE, Rosenfeld M., Stanojevic S., Swanney M.P., Thompson B.R.. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement.
62. Beydon N., Davis S.D., Lombardi E., Allen J.L., Arets H.G., Aurora P., Bisgaard H., Davis GM, Ducharme FM, Eigen H, Gappa M, Gaultier C, Gustafsson PM, Hall GL, Hantos Z, Healy et al.; American Thoracic Society/European Respiratory Society Working Group on Infant and Young Children Pulmonary Function Testing. An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med. 2007 Jun 15; 175(12): 1304-45.
63. Kiselnikova, L. Dental manifestations of hypophosphatasia in children and the effects of enzyme replacement therapy on dental status: a series of clinical cases/Kiselnikova L., Vislobokova E., Voinova V.//Clinical Case Reports. - 2020. - N 8. - Р. 911 - 918.
64. Whyte M.P., Rockman-Greenberg C., Ozono K., Riese R., Moseley S., Melian A., Thompson D.D., Bishop N., Hofmann C. Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia. J Clin Endocrinol Metab. 2016 Jan; 101(1): 334-42.
65. Kitaoka T., Tajima T., Nagasaki K., Kikuchi T., Yamamoto K., Michigami T., Okada S., Fujiwara I., Kokaji M., Mochizuki H., Ogata T., Tatebayashi K., Watanabe A., Yatsuga S., Kubota T., Ozono K. Safety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: Results from a Japanese clinical trial. Clin Endocrinol (Oxf). 2017 Jul; 87(1): 10 - 19.
66. Whyte M.P., Madson K.L., Phillips D., Reeves A.L., McAlister W.H., Yakimoski A., Mack K.E., Hamilton K., Kagan K., Fujita K.P., Thompson D.D., Moseley S., Odrljin T., Rockman-Greenberg C. Asfotase alfa therapy for children with hypophosphatasia. JCI Insight. 2016 Jun 16; 1(9): e85971. doi: 10.1172/jci.insight.85971. PMID: 27699270; PMCID: PMC5033855.
67. Padidela R., Yates R., Benscoter D., McPhail G., Chan E., Nichani J., Mughal M.Z., Myer C 4th, Narayan O., Nissenbaum C., Wilkinson S., Zhou S., Saal H.M. Characterization of tracheobronchomalacia in infants with hypophosphatasia. Orphanet J Rare Dis. 2020 Aug 6; 15(1): 204. doi: 10.1186/s13023-020-01483-9. PMID: 32762706; PMCID: PMC7407429.
68. Whyte MP, Simmons JH, Moseley S, Fujita KP, Bishop N, Salman NJ, Taylor J, Phillips D, McGinn M, McAlister WH. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Lancet Diabetes Endocrinol. 2019 Feb; 7(2): 93 - 105. doi: 10.1016/S2213-8587(18) 30307-3. Epub 2018 Dec 14. PMID: 30558909.
69. Geiger R., Strasak A., Treml B., Gasser K., Kleinsasser A., Fischer V., Geiger H., Loeckinger A., Stein J.I. Six-minute walk test in children and adolescents. J Pediatr. 2007 Apr; 150(4): 395-9, 399. e1-2. doi: 10.1016/j.jpeds.2006.12.052. PMID: 17382117.
70. Hofmann CEet al. Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study. J Clin Endocrinol Metab. 2019 Jul 1; 104(7): 2735 - 2747. doi: 10.1210/jc.2018-02335.
71. Genest F et al. Physical Function and Health-Related Quality of Life in Adults Treated With Asfotase Alfa for Pediatric-Onset Hypophosphatasia. JBMR Plus. 2020 Aug 4; 4(9): e10395. doi: 10.1002/jbm4.10395.
72. Seefried L., Kishnani P.S., Moseley S., Denker A.E., Watsky E., Whyte MP, Dahir KM. Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia. Bone. 2021 Jan; 142: 115664. doi: 10.1016/j.bone.2020.115664. Epub 2020 Sep 26. PMID: 32987199.
73. Seefried Let al. Effects of asfotase alfa in adults with pediatric-onset hypophosphatasia over 24 months of treatment. Bone. 2023 Oct; 175: 116856. doi: 10.1016/j.bone.2023.116856.
74. Рамазанова К.М., Калинченко Н.Ю., Витебская А.В. Нежелательные явления при длительном применении асфотазы альфа у пациентов с гипофосфатазией. Вопросы практической педиатрии. 2025. Т. 20. N 2. С. 91 - 98. DOI: 10.20953/1817-7646-2025-2-91-98.
75. Jiao Q., Ma G., Ni Q. Comprehensive treatment approaches for skeletal deformities in hypophosphatasia: a case study of ALPL gene variants. Front Pediatr. 2025 Jul 9; 13: 1562878. doi: 10.3389/fped.2025.1562878.
76. Kamran A., Jennings R.W. Tracheomalacia and Tracheobronchomalacia in Pediatrics: An Overview of Evaluation, Medical Management, and Surgical Treatment. Front Pediatr. 2019 Dec 12; 7: 512. doi: 10.3389/fped.2019.00512.
77. Adam M.P., Bick S., Mirzaa G.M, et al., et al., editors. Kathryn M Dahir, MD and Mark E Nunes, MD Hypophosphatasia.
[Internet] Seattle (WA): University of Washington, Seattle; 1993 - 2026 https: //www.ncbi.nlm.nih.gov/books/NBK1150/
78. Vislobokova E., Kiselnikova L., Voinova V., Sholokhova N. Dental findings in patients with hypophosphatasia Scientific Abstracts of the 14th Congress of the European Academy of Paediatric Dentistry (EAPD) Palazzo dei Congressi, Lake Lugano, Switzerland 20th to 23rd June 2018. Eur Arch Paediatr Dent 20, 127 - 237 (2019): P.152; https://doi.org/10.1007/s40368-018-0390-4.
79. Yamamoto H, Sasamoto Y, Miyamoto Y, Murakami H, Kamiyama N. A successful treatment with pyridoxal phosphate for West syndrome in hypophosphatasia. Pediatr Neurol. 2004 Mar; 30(3): 216-8.
80. de Roo MGA, Abeling N.G.G.M., Majoie C.B., Bosch A.M., Koelman J.H.T.M., Cobben J.M., Duran M., Poll-The B.T.. Infantile hypophosphatasia without bone deformities presenting with severe pyridoxine-resistant seizures. Mol Genet Metab. 2014 Mar; 111(3): 404 - 407.
81. Belachew D., Kazmerski T., Libman I., Goldstein A.C., Stevens S.T., Deward S., Vockley J., Sperling M.A., Balest A.L. Infantile hypophosphatasia secondary to a novel compound heterozygous mutation presenting with pyridoxine-responsive seizures. JIMD Rep. 2013; 11: 17 - 24.
82. Taketani T. Neurological Symptoms of Hypophosphatasia. Subcell Biochem. 2015; 76: 309-22.
83. Nunes M.L., Mugnol F., Bica I., Fiori .RM. Pyridoxine-dependent seizures associated with hypophosphatasia in a newborn. J Child Neurol. 2002 Mar; 17(3): 222-4.
84. Bianchi M.L., Bishop N.J.,
., Hofmann C., Jakob F., Roux C., Zillikens M.C.; Rare Bone Disease Action Group of the European Calcified Tissue Society. Hypophosphatasia in adolescents and adults: overview of diagnosis and treatment. Osteoporos Int. 2020 Aug; 31(8): 1445 - 1460.
85. Leung E.C., Mhanni A.A., Reed M., Whyte M.P., Landy H., Greenberg C.R. Outcome of perinatal hypophosphatasia in manitoba mennonites: a retrospective cohort analysis. JIMD Rep. 2013; 11: 73-8. doi: 10.1007/8904_2013_224. Epub 2013 Apr 12. PMID: 23580367.
86. ATS statement: Guidelines for the Six-Minute Walk Test. American Journal of Respiratory and Critical Care Medicine. Vol. 166, No. 1. Jul 01, 2002.
87. Borg GAV. Psycho-physical bases of perceived exertion. Med Sci Sports Exerc 1982; 14: 377 - 381.
88. Borg, G. Borg's Perceived Exertion and pain Scales. USA: Human Kinetics, 1998, p. 2.
89. Grant S., Aitchison T., Henderson E., Christie J., Zare S., McMurray J., Dargie H. A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise. Chest. 1999 Nov; 116(5): 1208-17.
90. Hypophosphatasia (HPP) Treatment & ManagementUpdated: Aug 07, 2019 Author: Ricardo R Correa Marquez, MD, EsD, FACP, FACE, FAPCR, CMQ, ABDA, FACHT; Chief Editor: Luis O Rohena, MD, MShttps://emedicine.medscape.com/article/945375-treatment#d6
91. Yang Y., Liu Z., Wei L., Taylor T.D., Xiao H. Prosthodontic Rehabilitation of a Patient with Hypophosphatasia Using Dental Implants: A Case Report with Seven Years Follow-Up. J Prosthodont. 2021 Dec; 30(9): 742 - 746. doi: 10.1111/jopr.13419.
92. Tournis S., Yavropoulou M.P., Polyzos S.A., Doulgeraki A. Hypophosphatasia. J Clin Med. 2021 Dec 1; 10(23): 5676. doi: 10.3390/jcm10235676.
93. Алексеева И.А., Кисельникова Л.П., Адмакин О.И., Данилова И.Г., Гетте И.Ф., Соколова К.В., Белая Ж.Е., Калинченко Н.Ю. Оценка состояния тканей зубов и пародонта по клиническим параметрам и лабораторным показателям фосфорно-кальциевого обмена в смешанной слюне у пациентов детского возраста с гипофосфатазией//Проблемы стоматологии. 2025. N. 3. С. 160 - 169. DOI: https://doi.org/10.18481/2077-7566-2025-21-3-160-16935,40
94. Алексеева И.А., Кисельникова Л.П., Островская И.Г. Клинико-лабораторная оценка эффективности включения пробиотического комплекса, содержащего S. salivarius M18, в профилактику стоматологических заболеваний у детей с нарушением фосфорно-кальциевого обмена. - Клиническая стоматология. - 2025; 28 (4): 6 - 12. DOI: 10.37988/1811-153X_2025_4_6.
95. Tsang Tiffany, Maya P Raghuwanshi. "Hypophosphatasia Misdiagnosed as Osteoporosis in a Young Girl." Journal of the Endocrine Society vol. 5, Suppl 1 A201-A202. 3 May. 2021, doi: 10.1210/jendso/bvab048.409.
96. Коняхина Г.П., Захарова Н.А. Лечебная физкультура для детей с ограниченными возможностями здоровья. Учебно-методическое пособие. Челябинск, 2019.
97. Методические рекомендации N 83. Медико-психологическая помощь детям с нарушением психического развития в системе комплексной реабилитации. Москва, ДЗМ, 2018 г. - 28 с.
98. Linglart A., Biosse-Duplan M. Hypophosphatasia. Curr Osteoporos Rep. 2016 Jun; 14(3): 95 - 105. doi: 10.1007/s11914-016-0309-0, Phillips D, Case LE, Griffin D, Hamilton K, Lara SL, Leiro B, Monfreda J, Westlake E, Kishnani PS. Physical therapy management of infants and children with hypophosphatasia. Mol Genet Metab. 2016 Sep; 119(1-2): 14-9. doi: 10.1016/j.ymgme.2016.06.010.
99. Simon S., Resch H. Treatment of hypophosphatasia. Wien Med Wochenschr. 2020 Apr; 170(5-6): 112 - 115. English. doi: 10.1007/s10354-020-00736-3.
100. Miyashita S., Ochiai S., Sakamoto С., Motegi E., Tada K., Fukasawa VP13. 10: Prenatal ultrasound findings in a survived case of perinatal lethal hypophosphatasia with enzyme replacement therapy started early in life//Ultrasound in Obstetrics & Gynecology. - 2020. - Т. 56. - С. 104 - 104.
101. Шолохова, Н.А. Визуализация поражений метафизов и эпифизов костей у новорожденных и детей раннего возраста/Н. А. Шолохова//Радиология - практика. - 2021. - N 5(89). - С. 82 - 90. - DOI 10.52560/2713-0118-2021-5-82-90. - EDN CDMJMI.
102. Kishnani P.S., Rehder C., Ozono K.,
., Del Angel G., Mowrey W.R., Balasubramanian M.,
., Rush E.T. Revisiting the Genetics of Hypophosphatasia. J Inherit Metab Dis. 2025 Nov; 48(6): e70083. doi: 10.1002/jimd.70083.
103. Correction to "Revisiting the Genetics of Hypophosphatasia". J Inherit Metab Dis. 2025 Nov; 48(6): e70113. doi: 10.1002/jimd.70113. Erratum for: J Inherit Metab Dis. 2025 Nov; 48(6): e70083. doi: 10.1002/jimd.70083. PMID: 41285421; PMCID: PMC12862687.
104. Riancho J.A. Diagnostic Approach to Patients with Low Serum Alkaline Phosphatase. Calcif Tissue Int. 2023 Mar; 112(3): 289 - 296. doi: 10.1007/s00223-022-01039-y. Epub 2022 Nov 8. PMID: 36348061.
105. Mornet, E., Taillandier, A., Domingues, C. et al. Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation. Eur J Hum Genet 29, 289 - 299 (2021). https://doi.org/10.1038/s41431-020-00732-6
106. Seefried, L., Petryk, A., del Angel, G. et al. Whole genome sequencing in adults with clinical hallmarks of hypophosphatasia negative for ALPL variants. Mol Biol Rep 51, 984 (2024). https://doi.org/10.1007/s11033024-09906-7
107. Hepp N., Frederiksen A.L., Duno M.,
.,
., Beck Jensen J.E. Biochemical, clinical and genetic characteristics in adults with persistent hypophosphatasaemia; Data from an endocrinological outpatient clinic in Denmark. Bone Rep. 2021; 15: 101101. Published 2021 Jun 28. doi: 10.1016/j.bonr.2021.101101.
108.
., Rusecka J.,
,
. Hypophosphatasia in children: From low alkaline phosphatase activity to diagnosis, genetic testing, and treatment options. A narrative review. Adv Clin Exp Med. 2026 Jan 13. doi: 10.17219/acem/205341. Epub ahead of print. PMID: 41528835.
109. Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., Grody W.W., Hegde M., Lyon E., Spector E., Voelkerding K., Rehm H.L.; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015 May; 17(5): 405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5. PMID: 25741868; PMCID: PMC4544753.
110. Dong Y., Wu X., Hao Y., Liu W., Hu X., Zhou J., Li X., Wang B. Epiregulin ameliorates ovariectomy-induced bone loss through orchestrating the differentiation of osteoblasts and osteoclasts. J Bone Miner Res. 2025 Mar 15; 40(3): 428 - 444. doi: 10.1093/jbmr/zjaf017. PMID: 39862425.
111. Donna Lee Wong, Connie Morain Baker. Comparison of the assessment scale. Pediatric Nursing. Pain in children. Jan-Feb 1988. Vol. 14. N 1.
112. Thacher T.D., Fischer P.R., Pettifor J.M., Lawson J.O., Manaster B.J., Reading J.C. Radiographic scoring method for the assessment of the severity of nutritional rickets. J Trop Pediatr 2000; 46: 132 - 139.
113. Zurutuza L., Muller F., Gibrat J.F., Taillandier A., Simon-Bouy B., Serre J.L., Mornet E. Correlations of genotype and phenotype in hypophosphatasia. Hum Mol Genet. 1999 Jun; 8(6): 1039-46. doi: 10.1093/hmg/8.6.1039. PMID: 10332035.
114. Fauvert D., Brun-Heath I., Lia-Baldini A.S., Bellazi L., Taillandier A., Serre J.L., de Mazancourt P., Mornet E. Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles. BMC Med Genet. 2009 Jun 6; 10: 51. doi: 10.1186/1471-2350-10-51. PMID: 19500388; PMCID: PMC2702372.
115. Del Angel G., Reynders J., Negron C., Steinbrecher T., Mornet E. Large-scale in vitro functional testing and novel variant scoring via protein modeling provide insights into alkaline phosphatase activity in hypophosphatasia. Hum Mutat. 2020 Jul; 41(7): 1250 - 1262. doi: 10.1002/humu.24010. Epub 2020 Mar 18. PMID: 32160374; PMCID: PMC7317754.
116. Shajani-Yi Z., Ayala-Lopez N., Black M., Dahir K.M. Urine phosphoethanolamine is a specific biomarker for hypophosphatasia in adults. Bone. 2022 Oct; 163: 116504. doi: 10.1016/j.bone.2022.116504. Epub 2022 Jul 22. PMID: 35878747.
117. Michael P. Whyte, M.D. Hypophosphatasia: An Overview For Physicians and Medical Professionals.
118. Hayashi-Sakai S., Hayashi T., Sakamoto M., Sakai J., Shimomura-Kuroki J., Nishiyama H., Katsura K., Ike M., Nikkuni Y., Nakayama M., Soga M., Kobayashi T. Nondestructive Microcomputed Tomography Evaluation of Mineral Density in Exfoliated Teeth with Hypophosphatasia. Case Rep Dent. 2016; 2016: 4898456. doi: 10.1155/2016/4898456. Epub 2016 Oct 25. PMID: 27847653; PMCID: PMC5099477.
119. Okawa R., Nakamoto T., Matayoshi S. et al. Evaluation of alveolar bone hypomineralization in pediatric hypophosphatasia using orthopantomography. Sci Rep 12, 1211 (2022). https://doi.org/10.1038/s41598-022-05171-5
120. Kishnani P.S., Molecular Genetics and Metabolism (2017), http://dx.doi.org/10.1016/j.ymgme.2017.07.010
121. Baroncelli G.I., Carlucci G., Freri E., Giuca M.R., Guarnieri V., Navarra G., Toschi B., Mora S. The diagnosis of hypophosphatasia in children as a multidisciplinary effort: an expert opinion. J Endocrinol Invest. 2024 Mar; 47(3): 739 - 747. doi: 10.1007/s40618-023-02199-w. Epub 2023 Sep 26. Erratum in: J Endocrinol Invest. 2024 Dec; 47(12): 3137. doi: 10.1007/s40618-024-02403-5. PMID: 37752373; PMCID: PMC10904512.
122.
., Schmidt F.N., von Vopelius E., Delsmann M.M., Schmidt C., Jandl N.M., Oheim R., Barvencik F. Bone healing and reactivation of remodeling under asfotase alfa therapy in adult patients with pediatric-onset hypophosphatasia. Bone. 2021 Feb; 143: 115794. doi: 10.1016/j.bone.2020.115794. Epub 2020 Dec 8. PMID: 33301963.
123. Inoue R., Ishizawa K., Takamura Y., Kosokabe F., Takeuchi K., Inoue D. Adult Hypophosphatasia in a Middle-Aged Patient With Recurrent Fractures: Prevention of New Fractures With Asfotase Alfa. JCEM Case Rep. 2025 Sep 25; 3(11): luaf210. doi: 10.1210/jcemcr/luaf210. PMID: 41018175; PMCID: PMC12461573.
124. Seefried L., Dahir K., Petryk A.,
., Linglart A.,
, Ozono K., Fang S., Rockman-Greenberg C, Kishnani PS. Burden of Illness in Adults With Hypophosphatasia: Data From the Global Hypophosphatasia Patient Registry. J Bone Miner Res. 2020 Nov; 35(11): 2171 - 2178. doi: 10.1002/jbmr.4130. Epub 2020 Aug 10. PMID: 32654183.
125.
, Hermann X., Hepp N., Sonnesen L. Oro-Dental Characteristics in Patients With Adult-Onset Hypophosphatasia Compared to a Healthy Control Group-A Case-Control Study. J Oral Rehabil. 2025 Jan; 52(1): 64 - 74. doi: 10.1111/joor.13878. Epub 2024 Oct 11. PMID: 39394635; PMCID: PMC11680502.
126. Bowden S.A., Foster B.L. Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy. Drug Des Devel Ther. 2018 Sep 24; 12: 3147 - 3161. doi: 10.2147/DDDT.S154922. PMID: 30288020; PMCID: PMC6161731.
127. Savarirayan R., Tunkel D.E., Sterni L.M., Bober M.B., Cho T.J., Goldberg M.J., Hoover-Fong J., Irving M., Kamps S.E., Mackenzie W.G., Raggio C., Spencer S.A., Bompadre V., White K.K.; on behalf of the Skeletal Dysplasia Management Consortium. Best practice guidelines in managing the craniofacial aspects of skeletal dysplasia. Orphanet J Rare Dis. 2021 Jan 14; 16(1): 31. doi: 10.1186/s13023-021-01678-8. PMID: 33446226; PMCID: PMC7809733.
128. Seefried L., Genest F., Hofmann C., Brandi M.L., Rush E. Diagnosis and Treatment of Hypophosphatasia. Calcif Tissue Int. 2025 Mar 6; 116(1): 46. doi: 10.1007/s00223-025-01356-y. PMID: 40047955; PMCID: PMC11885340.
- Гражданский кодекс (ГК РФ)
- Жилищный кодекс (ЖК РФ)
- Налоговый кодекс (НК РФ)
- Трудовой кодекс (ТК РФ)
- Уголовный кодекс (УК РФ)
- Бюджетный кодекс (БК РФ)
- Арбитражный процессуальный кодекс
- Конституция РФ
- Земельный кодекс (ЗК РФ)
- Лесной кодекс (ЛК РФ)
- Семейный кодекс (СК РФ)
- Уголовно-исполнительный кодекс
- Уголовно-процессуальный кодекс
- Производственный календарь на 2027 год
- МРОТ 2027
- ФЗ «О банкротстве»
- О защите прав потребителей (ЗОЗПП)
- Об исполнительном производстве
- О персональных данных
- О налогах на имущество физических лиц
- О средствах массовой информации
- Производственный календарь на 2026 год
- Федеральный закон "О полиции" N 3-ФЗ
- Расходы организации ПБУ 10/99
- Минимальный размер оплаты труда (МРОТ)
- Календарь бухгалтера на 2026 год
- Частичная мобилизация: обзор новостей
- Постановление Правительства РФ N 1875